|
|
|
|
| Symbol | Name | Industry | Sector | Exchange | Cap | Cap, mln | Last | Change | Change, % | Volume |
| |
Acumen Pharmaceuticals Inc | Biotechnology | Healthcare | NASDAQ | Micro | 193.17 |
2.68 |
0.17 | 6.77 | 382,973 |
| |
Abbott Laboratories | Medical Devices | Healthcare | NYSE | Large | 174,290 |
101.05 |
0.36 | 0.36 | 11,687,339 |
| |
Abacus Global Management Inc | Insurance - Life | Financial Services | NYSE | Small | 793.75 |
8.72 |
0.16 | 1.87 | 479,511 |
| |
ADC Therapeutics S.A. | Biotechnology | Healthcare | NYSE | Small | 475.15 |
3.86 |
0.05 | 1.31 | 541,691 |
| |
Bitwise Trendwise Ether & Treasuries Rotation Strategy Etf | Exchange Traded Fund | Financial Services Etf | NYSE | Micro | 5.96 |
35.74 |
0.74 | 2.11 | 381 |
| |
Aeva Technologies Inc | Software - Infrastructure | Technology | NASDAQ | Small | 864.95 |
14.12 |
0.52 | 3.82 | 1,035,181 |
| |
FINQ DOLLAR NEUTRAL U.S. Large Cap AI-Managed Equity Etf | Exchange Traded Fund | Financial Services Etf | NYSE | Micro | 3.01 |
25.42 |
0.37 | 1.48 | 225 |
| |
Air Industries Group | Aerospace & Defense | Industrials | NYSE | Micro | 15.11 |
3.25 |
0.09 | 2.85 | 33,449 |
| |
Air T Inc | Conglomerates | Industrials | NASDAQ | Micro | 60.81 |
22.40 |
-0.1 | -0.44 | 3,116 |
| |
Alumis Inc | Biotechnology | Healthcare | NASDAQ | Mid | 2,931.94 |
22.89 |
0.37 | 1.64 | 1,209,466 |
Upgrade to Pro to unlock full screener results with no delays, customizable filters, real-time alerts for new matches, and advanced backtesting on historical data.
|
|
|
 MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend-following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average called the "signal" line is plotted on top of the MACD to show buy or sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences.
|
|
| |
